Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Mayo Clinic proceedings - 1 Dec 2010

Pruthi Sandhya, Gostout Bobbie S, Lindor Noralane M

Abstract excerpt

Women with a germline BRCA1 or BRCA2 mutation or a hereditary predisposition for breast and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general US population. Health care professionals can be instrumental in identifying women at increased risk through obtaining a comprehensive family history and becoming familiar with family history characteristics associated with hereditary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to BRCA1 gene
Share to BRCA2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21123638
DOI: 10.4065/mcp.2010.0414
PMCID: PMC2996153

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.PMID 21123638Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Identifying and managing hereditary risk of breast and ovarian cancer.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

Management of women who have a genetic predisposition for breast cancer.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.Semantic proximity Read ↗

Hereditary breast-ovarian cancer: clinical findings and medical management.Semantic proximity Read ↗

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.Semantic proximity Read ↗

Hereditary gynecologic cancers: risk assessment, counseling, testing and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.